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Background: To describe the incidence, demographic and clinical features of 1187 localized gingival enlarge-
ments.
Material and Methods: 1187 cases of localized gingival enlargements diagnosed during a 20-year period were 
retrospectively collected. The patients’ gender and age, as well as the main clinical features of the tumors were 
retrieved from the biopsy report forms.
Results: The 1187 localized gingival enlargements represented 6.23% of 19.044 biopsies performed during the 
study period. 756 females and 427 males were affected with a mean age of 41.92±19.68 years. The lesions appeared 
as smooth (52.4%), granular (17.9%) or rough (13.16%) tumors, elastic (50.73%) or soft (29.56%) in consistency 
and red (60.8%), normal (28.58%) or white (8.17%) in color. The majority of the lesions (85.17%) were reactive in 
origin with pyogenic granuloma being the most common. In 1.1% of the cases a diagnosis of malignant lesion was 
rendered.
Conclusions: All localized gingival enlargements should be submitted for microscopic examination because in 
approximately 1% of cases they are malignant.
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Introduction
Localized gingival enlargements (LGEs) are common 
in clinical practice (1,2) and are usually of reactive ori-
gin (1,2) developing as a response to chronic local irrita-
tion or trauma (3). Most published studies focus on reac-
tive LGEs (3-6) i.e. fibrous hyperplasia (FH), pyogenic 
granuloma (PG), peripheral ossifying fibroma (POF) 
and peripheral giant cell granuloma (PGCG). However, 
benign and malignant neoplasms (2), lesions of dysplas-
tic origin (7) and lesions representing manifestations of 
systemic diseases (2) may also occur. Truschnegg et al. 
(8) and Bernick (9) studied 92 and 864 cases of LGEs, 
respectively. However, in the first study the number of 
cases was too small for valid conclusions to be made, 
while in the later LGEs were studied together with lo-
calized enlargements of the palate.
The aim of the present study is to report the incidence, 
demographic and clinical features of 1187 LGEs.
Material and Methods
In this retrospective study all Biopsy Request Forms 
accompanying biopsies submitted to our Laboratory 
from 1995 to 2015 were searched using the keywords 
“tumor” and “gingiva” in the predefined list of clini-
cal terms.  For each case the patient’s gender and age, 
location and clinical features of the lesions were tabu-
lated. Final diagnosis was retrieved from the Pathology 
report. Cases reported as localized on the “alveolar 
Diagnosis (number of lesions) %
Pyogenic granuloma (330) 27.8
Peripheral ossifying fibroma (325) 27.38
Fibrous hyperplasia (163) 13.73
Peripheral giant cell granuloma (147) 12.38
Fibroepithelial hyperplasia (46) 3.88
Papilloma (27) 2.27
Gingival inflammation (25) 2.11
Giant cell fibroma (23) 1.94
Peripheral odontogenic tumors (17): Peripheral odontogenic fibroma (12); Peripheral ameloblastoma (2); 
Peripheral dentinogenic ghost cell tumor (2); Peripheral odontogenic myxoma (1)
1.43
Malignant lesions (13): Squamous cell carcinoma (6); Lymphoma (2); Extramedullary plasmatocytoma (2); 
Metastatic breast carcinoma (1); Metastatic lung carcinoma (1); Metastatic prostate carcinoma (1)
1.1
Other (71): Fistula granuloma (10); Hemangioma (8); Epithelial hyperplasia (5) Wart (5); Localized 
juvenile spongiotic gingival hyperplasia (4); Granulation tissue (4); Peripheral nerve sheath tumor (3); 
Abscess (3); Benign papillary lesion (3); Plasma cell granuloma (2); Benign fibrous histiocytoma (2); 
Fibromyxoma (2); Condyloma acuminatum (2);  Intramucosal nevus (1); Exostosis (1); Mild epithelial 
dysplasia (1); Focal mucinosis (1); Verruciform xanthoma (1); Thrombus (1); Fibrolipoma (1); Intraoral 
sebaceous hyperplasia (1); Brown tumor (1); Lysosomal storage disease (1); Epithelioid cell histiocytoma 
(1); Benign fibrous proliferation (1); Lipoma (1); Myxoid calcified hamartoma (1); Myofibroma (1); Bone 
hamartoma (1); Bone choristoma (1); Gingival cyst of adult (1)
5.98
Table 1: Diagnosis of localized gingival enlargements.
mucosa” or “edentulous alveolar ridge” were excluded 
from the study. 
Results
A total of 1187 cases of LGEs affecting 1187 patients 
represented 6.23% of 19.044 biopsies accessioned dur-
ing the study period. Diagnoses are tabulated in Table 
1. Most lesions (85.17%) were reactive in origin, with 
PG being the most common (27.8%), followed by POF 
(27.38%), FH (13.73%), PGCG (12.38%) and fibroepi-
thelial hyperplasia (FEH) (3.88%). Other common le-
sions in descending order were papilloma (2.27%), gin-
gival inflammation (2.11%) giant cell fibroma (1.94%) 
and peripheral odontogenic tumors (1.43%). Malignant 
lesions were rare (1.1%). 
In Figures 1 and 2 gender and age distribution for all 
LGEs as well as for particular entities diagnosed in 
at least 10 patients are tabulated. As a whοle, LGEs 
showed a female predominance, with 756 cases (63.91%) 
occurring in female patients compared to 427 (36.09%) 
in males (male to female ratio 0.56:1). Most patients 
were in the 4th – 6th decade of life, with a mean age of 
41.92±19.68 years (median age 43 years). The difference 
between the mean age of males (41.12±21.2 years, me-
dian age 42 years) and females (42.4±18.76 years, me-
dian age 43 years) was not statistical significant. Giant 
cell fibroma and papilloma occurred in younger patients 
and malignant lesions in older patients, compared to 
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Fig. 1: Gender of patients (for lesions occurring at least in 10 patients).
Fig. 2: Age of patients related to decade of life (for lesions occurring at least in 10 patients).
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LGEs. LGEs showed a slight predilection for the maxil-
la (51.73%), compared to the mandible (48.28%), as well 
as for anterior areas (58.49%), compared to posterior 
ones (41.51%). They were more common in the anterior 
maxilla (33.02%), followed by the anterior mandible 
(25.48%), posterior mandible (22.79%) and posterior 
maxilla (18.7%). FEH, papilloma and malignant lesions 
occurred more frequently in the posterior part of the 
mandible (Fig. 3). 
Fig. 3: Site of localized gingival enlargements (for lesions occurring at least in 10 patients).
Clinically LGEs were described as sessile (50.9%) or 
pediculated masses (49.1%); of red (60.8%), normal 
(28.58%) or white (8.17%) color; elastic (50.73%) or 
soft (29.56%) in consistency; and with smooth (52.4%), 
granular (17.9%) or rough (13.16%) surface. There were 
few significant divergences from the aforementioned 
clinical characteristics.  Concerning pediculus, lesions 
that differed were gingival inflammation, peripheral 
odontogenic tumors and malignant lesions, the vast ma-
jority of which were sessile (77.27%, 100% and 88.89% 
respectively). The majority of PG, PGCG, and gingival 
inflammation (85.13%, 84.78% and 91.3% respectively) 
were red in color, whereas 37.5 % of papillomas and 
52.38% of giant cell fibromas were white. In contrast 
to all the other LGEs, papillomas (41.67%) and ma-
lignant lesions (25%) most commonly had a granular 
rather than smooth surface. Also papillomas (29.17% 
of cases) and FEH (17.5% of cases) were more possible 
to have a papillary surface, while malignant lesions 
(25% of cases) and giant cell fibromas (23.81% of cases) 
to have a rough one. LGEs measured approximately 
1.15±0.8cm (median size 1cm) in the largest diameter. 
Malignant lesions had the largest mean size among 
LGEs (1.98±0.84cm.), while papillomas (0.58±0.31 cm) 
and giant cell fibromas (0.63±0.35cm) the lowest. LGEs 
were asymptomatic in 82.39% of cases justifying the 
long duration of 12.76±21.61 months (median duration 5 
months) before diagnosis. FH (20.33±32.84 months) and 
giant cell fibroma (33.53±39.48 months) had the longest 
mean duration before diagnosis, whereas malignant le-
sions (2.64±1.98 months) and gingival inflammation 
(6.12±9.23 months) had the shortest. 
Recurrence was reported in POF (7 cases), PG (5 cases), 
PGCG (4 cases), FH (2 cases) papilloma and peripheral 
odontogenic fibroma (1 case each). 
Discussion
In this retrospective study the incidence, demograph-
ic and clinical features of 1187 LGEs were described, 
while in previous studies only reactive LGEs were in-
cluded (3-6). They represented 6.23% of all biopsies 
accessioned in the study period which is higher than 
the percentage of 4% seen in adults (10) and 2.3% in 
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children up to 16 year-old (11) reported in other studies 
during a 30-year period.
Most LGEs, PG, POF, FH and PGCG were of reactive 
origin, and represented 5.35% of all biopsies of the study 
period which is comparable to the frequency reported in 
previous studies, 6.7% (3), 6.4% (4), 5% (5) and 3.6% 
(6) respectively. Although in the aforementioned stud-
ies FH was the most common reactive LGE, represent-
ing 31.8% (3), 61.2% (4), 45.5% (5), and 61% (6), in the 
present study PG was the most common (34.2%), fol-
lowed by POF (33.68%) and FH (16.9%). Differences 
in the relative frequency of reactive LGEs in various 
studies (3-6) have been attributed to  heterogeneity of 
the study populations or to different histopathologic cri-
teria (3). The clinical features of the four reactive LGEs 
are in accordance with previous reports (3). In 18 cases 
of reactive LGEs recurrence was recorded, but as the 
data of the present study were extracted from biopsy 
report forms, conclusions on recurrence rates cannot be 
drawn.
Peripheral odontogenic tumors represented 1.43% of all 
LGEs and 0.09% of all specimens submitted for histo-
pathologic examination during the study period, while 
in previous studies these tumors represented 0.05% of 
all specimens submitted for histopathologic examina-
tion (13), and their relative frequency among all odonto-
genic tumors ranged from 0.1% to 8.9% (13).  Peripheral 
odontogenic fibroma was the most common peripheral 
odontogenic tumor followed by peripheral ameloblas-
toma which is in accordance with previous studies (13-
15). Similarly, according to a previous report, peripher-
al odontogenic fibroma in our study, exhibited a female 
predominance, a predilection for middle aged patients, 
and for the anterior part of the maxilla and the mandible 
(16). Peripheral ameloblastoma represents 0-10% of all 
ameloblastomas (13), while the two cases of peripheral 
dentinogenic ghost cell tumors  and the single case of 
peripheral odontogenic myxoma detected in our series 
are extremely unusual tumors, as only 50 cases (17) and 
6 cases (18), respectively, have been included in recent 
reviews. 
Squamous cell carcinoma was the most common ma-
lignant LGE in our study. It presented in four female 
and two male patients, with a mean age of 58.3 years. 
All lesions arose on the mandibular gingiva, five on the 
posterior and one on the anterior. Gingival squamous 
cell carcinoma accounts for less than 10% to as high as 
30% of all oral squamous cell carcinomas and shows 
almost equal gender distribution and a predilection for 
older patients (19). It occurs most commonly on the pos-
terior mandibular gingiva as an exophytic mass, usually 
ulcerated (19). It is noteworthy that many practitioners 
report reactive gingival lesions in the differential diag-
nosis of gingival squamous cell carcinoma (19), while in 
our study, a provisional diagnosis of reactive lesion was 
given in half of the cases of squamous cell carcinoma. 
Three cases of metastatic tumors, two cases of lym-
phoma and two cases of extramedullary plasmatocyto-
mas presenting as LGE were also detected in our mate-
rial. The gingiva is the most common soft tissue site of 
metastasis (20), and the 4th most common site of oral 
lymphoma development followed by the maxilla, palate 
and the mandible (21,22). The lesions may mimic reac-
tive lesions (20). Metastatic tumors are seen in the pres-
ence of widespread disease, and lung, breast and kid-
ney carcinoma metastasize more often to the oral soft 
tissues compared to other tumors (20). In our material, 
the metastatic tumors originated from the breast, lung 
and prostate; they occurred in two male and one female 
patients with a mean age 64 years; two lesions presented 
in the posterior mandibular gingiva and the other in the 
anterior maxillary gingiva.
Conclusions
LGE are common in clinical practice and most are of 
reactive origin, but approximately 1% are malignant. 
Therefore, all LGEs should be submitted for microscop-
ic examination and not diagnosed as benign based on 
the clinical impression and expertise.
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